Concepedia

Publication | Open Access

Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients

142

Citations

19

References

2009

Year

Abstract

Three-month outcomes of patients receiving low-dose intravenous recombinant tissue plasminogen activator therapy in the present study were similar to those from postmarketing surveys using 0.9 mg/kg alteplase.

References

YearCitations

Page 1